Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Case Report Volume 5 Issue 3

Coronavirus Disease (COVID-19) in a Patient with Chronic HCV-Infection Receiving Direct-Acting Antiviral Agents

AA Yakovlev, SS Suleimanova*, DL Sulima, VN Koryagin, NM Kravchuk and VA Larionov

Department of Infectious Disease, the Pavlov First Saint Petersburg, State Medical University, Russian Federation

*Corresponding Author: SS Suleimanova, Department of Infectious Disease, the Pavlov First Saint Petersburg, State Medical University, Russian Federation.

Received: January 28, 2022; Published: February 09, 2022

Case report

A female patient Sh. aged 58, was observed in the EXCLUSIVE clinic with a diagnosis

Chronic HCV-infection 1b genotype

  • Replicative option: Chronic HCV RNA viremia, low viral load 4.3×105 IU/ml.
  • Clinical form: Combined HCV-syndrome:

HCV-associated chronic steatohepatitis (S2/0.50) with moderate necroinflammatory activity (A1/0.35) and minimal fibrosis (F1/0.33).

References

  1. Chau TN., et al. “SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases”. Hepatologу2 (2004): 302-310.
  2. Chai X., et al. “Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection”. bioRxiv (2020).
  3. Qingxian Cai, et al. “COVID-19: Abnormal liver function tests”. Journal of Hepatology3 (2020): 566-574.
  4. Boettler T., et al. “Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic”. JHEP Reports5 (2020).
  5. Cai Q., et al. “Obesity and COVID-19 severity in a designated hospital in Shenzhen, China”. Diabetes Care 7 (2020): 1392-1398.
  6. Beigel J.H., et al. “Remdesivir for the treatment of covid-19 - preliminary report”. NewEngland Journal of  Medicine 10 (2020): 994.

Citation

Citation: SS Suleimanova., et al. “Coronavirus Disease (COVID-19) in a Patient with Chronic HCV-Infection Receiving Direct-Acting Antiviral Agents". Acta Scientific Gastrointestinal Disorders 5.3 (2022): 02-04.

Copyright

Copyright: © 2022 SS Suleimanova., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


Contact US